Trinity Biotech (TRIB) Projected to Post Earnings on Thursday

Trinity Biotech (NASDAQ:TRIB) will likely be releasing its earnings data before the market opens on Thursday, April 3rd. Analysts expect the company to announce earnings of ($0.30) per share for the quarter.

Trinity Biotech Trading Down 5.4 %

TRIB opened at $0.64 on Thursday. Trinity Biotech has a 1-year low of $0.63 and a 1-year high of $3.55. The company has a market cap of $11.50 million, a P/E ratio of -0.28 and a beta of 1.20. The company’s 50 day moving average is $0.78 and its 200-day moving average is $1.11.

Analyst Ratings Changes

Separately, StockNews.com began coverage on shares of Trinity Biotech in a report on Saturday, March 22nd. They issued a “sell” rating on the stock.

Trinity Biotech Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.